3183-22-0

Basic information

• Product Name: ethyl N-propan-2-ylglycinate
• CAS NO: 3183-22-0
• Molecular Formula: C₇H₁₅NO₂
• Molecular Weight: 145.1995
• Mol File: 3183-22-0.mol
• Article Data: 20

Chemical Properties

• Boiling Point: 174.7°C at 760 mmHg
• Flash Point: 59.4°C
• Density: 0.926g/cm³
• Vapor Pressure: 1.19mmHg at 25°C
• Refractive Index: 1.421
• CAS DataBase Reference: ethyl N-propan-2-ylglycinate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl N-propan-2-ylglycinate(3183-22-0)
• EPA Substance Registry System: ethyl N-propan-2-ylglycinate(3183-22-0)

Safety Data

• Hazardous Substances Data: 3183-22-0(Hazardous Substances Data)

Usage

General Description

Ethyl N-propan-2-ylglycinate is a chemical compound that is commonly used as a skin conditioning agent and emollient in cosmetic formulations. It is derived from glycine, an amino acid, and is known for its moisturizing and soothing properties. Ethyl N-propan-2-ylglycinate is also used in personal care products such as lotions, creams, and hair care products due to its ability to improve the texture and softness of the skin and hair. Additionally, it is known for its mild and gentle nature, making it suitable for use in products designed for sensitive or delicate skin.

Upstream product

• 105-36-2 ethyl bromoacetate 
• 108-18-9 diisopropylamine 
• 623-33-6 glycine ethyl ester hydrochloride 
• 67-64-1 acetone 
• 105-39-5 chloroacetic acid ethyl ester 
• 75-31-0 isopropylamine 

Downstream Products

• 18030-32-5 [(3,5-Dibromo-2-diacetylamino-benzyl)-isopropyl-amino]-acetic acid ethyl ester 
• 18053-17-3 [(2-Acetylamino-6-chloro-benzyl)-isopropyl-amino]-acetic acid 
• 6939-16-8 N-Nitroso-N-isopropyl-glycin 
• 161465-38-9 N-(1-methylethyl)-N-(4-nitrobenzoyl)glycine 
• 83797-06-2 ethyl N-(3,5-dichlorobenzoyl)-N-isopropylaminoacetate 
• 1172117-39-3 ethyl 2-(N-isopropyl-2-methyl-6-vinylbenzamido)acetate 

Relevant articles and documents

Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitors

A series of novel phenol ether derivatives were designed, synthesized, and evaluated as non-covalent proteasome inhibitors. Most compounds exhibited moderate to excellent proteasome inhibitory activity. In particular, compound 18x proved to be the most po

HETEROCYCLIC SULFONAMIDE DERIVATIVE AND MEDICINE COMPRISING SAME

The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the DESCRIPTION, or a pharmaceutically acceptable salt thereof. The compound has a superior TRPA1 antagonist activity, and can provide a medicament useful for the prophylaxis or treatment of diseases involving TRPA1 antagonist and TRPA1.

Equimolar CO2 capture by N-substituted amino acid salts and subsequent conversion

Steric bulk controls CO2 absorption: N-substituted amino acid salts in poly(ethylene glycol) reversibly absorb CO2 in nearly 1:1 stoichiometry. Carbamic acid is thought to be the absorbed form of CO 2; this was supported by NMR and in situ IR spectroscopy, and DFT calculations. The captured CO2 could be converted directly into oxazolidinones and thus CO2 desorption could be sidestepped. Copyright